Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Biotechnology company Vertex Pharmaceuticals (VRTX) reported mixed results for the fourth quarter of 2024. While revenue surpassed analyst ...

Bernstein SocGen Group adjusted its price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), increasing it slightly from $441.00 to $444.00 while maintaining a Market Perform rating. With a ...

Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the ... Although Vertex has seen solid sales growth lately, its operating margin has contracted by 1,150 bps from 51.4% in ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inspire Medical Systems (INSP – Research ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the ... Although Vertex has seen solid sales growth lately, its operating margin has contracted by 1,150 bps from 51.4% in ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and Vertex Pharmaceuticals (VRTX ... of our Style Scores system. The proven Zacks Rank ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session ... estimate changes and provides a simple, actionable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy ...